PZ Cormay

PZ Cormay P/TBV

The Price to Tangible Book Value (P/TBV) of PZ Cormay (CRM.WA) as of Oct 24, 2026 is 1.07. In the previous year, Price to Tangible Book Value (P/TBV) was 1.74 — a change of -38.49% (lower).

P/TBV

1.07

YoY

-38.49%

Last updated:

Price to Tangible Book Value (P/TBV) of PZ Cormay is 2025 1.07 . Price to Tangible Book Value (P/TBV) of PZ Cormay was 2024 1.74 . It decreases by -38.49% lower compared to the previous year.

The PZ Cormay P/TBV history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/TBV
Date
P/TBV
Jan 1, 2018
0.80 PLN
Jan 1, 2019
0.83 PLN
Jan 1, 2020
1.02 PLN
Jan 1, 2021
1.00 PLN
Jan 1, 2022
1.21 PLN
Jan 1, 2023
1.46 PLN
Jan 1, 2024
1.74 PLN
Jan 1, 2025
1.07 PLN
The PZ Cormay P/TBV history
YEARP/TBVYoY
1.07-38.49%
1.74+19.14%
1.46+20.93%
1.21+20.38%
1.00-1.32%
1.02+22.77%
0.83+2.99%
0.80+8.55%
0.74-41.41%
1.26+93.50%
0.65-26.38%
0.89—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PZ Cormay Stock analysis

What does PZ Cormay do? PZ Cormay SA manufactures diagnostic reagents and laboratory equipment, offering products like biochemical rapid tests, vacuette tubes, and devices including ACCENT-300, ACCENT-200, PRESTIGE 24i, LIVIA analyzers, MYTHIC 18 hematology analyzers, and IChem 100 urinalysis apparatus. The company serves clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation, and specific protein recognition segments. Its products are distributed through Orphee SA, which acquired 100% stake in TT Management Sp z o o on September 1, 2014, to transfer Cormay group's production and distribution activities. Orphee SA, now holding full control of Cormay's operations, manages the distribution of PZ Cormay SA's diagnostic reagents and laboratory equipment. The firm's revenue comes from selling biochemical analyzers, hematology analyzers, and related products to healthcare facilities and laboratories. PZ Cormay SA's product portfolio includes drugs, biochemical rapid tests, and devices such as vacuette tubes, targeting clinical and diagnostic markets with a focus on specialized equipment for medical analysis. The company's revenue streams are derived from the sale of its analytical devices and reagents, with Orphee SA handling the distribution after the 2014 restructuring. PZ Cormay SA's products are used in clinical chemistry, hematology, and other diagnostic segments, with specific equipment like the ACCENT-300 and MYTHIC 18 being key offerings. The restructuring plan transferred production and distribution to Orphee SA, enabling streamlined operations and market access. PZ Cormay is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PZ Cormay stock

Price to Tangible Book Value (P/TBV) of PZ Cormay is 1.07 in 2025.

Price to Tangible Book Value (P/TBV) of PZ Cormay changed from 1.74 to 1.07, representing a -38.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Price to Tangible Book Value (P/TBV) PZ Cormay since 2006 – with annual values, charts, and detailed analysis.

P/TBV compares the stock price to tangible book value per share, excluding goodwill and intangibles. It provides a conservative asset-based valuation.

To evaluate Price to Tangible Book Value (P/TBV)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Price to Tangible Book Value (P/TBV).

A 'good' varies by industry and company stage. On Eulerpool, you can compare Price to Tangible Book Value (P/TBV)'s PZ Cormay with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — PZ Cormay

All Key Metrics — PZ Cormay